Women’s Heart Health Initiative Abbott Vascular/SCAI OB/GYN Pilot

Presentation Title Date 2Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Program objectives To increase awareness and screening of heart disease in women using OBGYNs as their primary care physician To engage OBGYNs with clinical and interventional cardiologists to develop a screening and treatment algorithm that works for their institution

Presentation Title Date 3Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Abbott Role Identify qualified/motivated sites Focus on community hospitals Engage clinical cardiologists, ICs, OBGYNs, NPs Financial support of dinner programs, lunch & learns, ACOG local society programs Facilitate “best practices” webcasts, conference calls – minimum of 2 with participants Provide patient education brochures for office and mammography suites Provide slide presentations for referring physician education and patient education Provide CEU program on women’s heart health issues for cath lab staff and other allied professionals within the hospital system

Presentation Title Date 4Company Confidential LTXXXXXXX ©2009 Abbott Laboratories SCAI Support Provide input/consultation for development of screening “checklist” for review by NP or nurse prior to exam Co-exploration of ACOG and NAMS platform presentations Co-branded screening tool through use of the SCAI logo Development and execution of publication plan “Master Center” at Geisinger led by Dr. Skelding

Presentation Title Date 5Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Rationale More and more women are choosing to use their OB/GYN as their PCP OB/GYNs deliver excellent preventive care and screening Paps, mammograms HPV, chlamydia, colo-rectal cancer, etc. OB/GYNs instill tremendous loyalty and trust in their patients Heart disease is the #1 killer of women – let’s build a bridge or partnership with the cardiology and OB/GYN community to offer optimal management of this major health care issue Abbott Vascular is committed to improving awareness, diagnosis, and treatment in women with heart disease through research, collaboration with key societies, and novel pilot (proof of concept) programs

Presentation Title Date 6Company Confidential LTXXXXXXX ©2009 Abbott Laboratories OB/Gyn Pilot Logistics Referral options provided to patient with standard hospital screening language. Woman fills out screening form at OB/Gyn office. BP Recorded in exam room. OB/Gyn office sends forms back to Abbott Nurse tallies form and determines if referral is appropriate. Sends aggregate data to SCAI-WIN to publish findings. Individual sites get their data. Abbott sends data to third party vendor for analysis. Goals: Partner OB/Gyns with Cardiologists to raise awareness about cardiovascular disease in women Increase diagnoses and referrals of women with cardiovascular disease

Presentation Title Date 7Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Peoria is Site #3

Presentation Title Date 8Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Key Program Architects Dr. Bonnie Weiner- IC, Past President SCAI-WIN, Director, Cath Lab at U Mass Dr. Kimberly Skelding - IC, SCAI-WIN, SCAI Trustee, Geisinger Medical Center (Danville, PA) Dr. Roxana Mehran, IC, SCAI-WIN, Mt. Sinai (New York) Dr. Robert Wild, PhD, MPH, NCMP - OB/GYN, Editorial Board, NAMS; Editorial Board, Journal of Women’s Health, U of Oklahoma Dr. Charles Simonton – IC, CSO, Abbott Vascular Dr. Poornima Sood, MPH – Medical Director, Abbott Vascular

Presentation Title Date 9Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Society Partners ACC Chief Medical Officer, Dr. Solomon, described this pilot as “brilliant.” We are partnering with ACC to mine their NCDR database to identify best practices to improve PCI outcomes in women. We are partnering with WomenHeart, the largest coalition of women with heart disease, to support educational programs for women and their primary care physicians. SCAI-WIN has co-branded the screening tool and hopes to publish the results from the 3000 patients and to use these results to apply for a larger grant to expand these educational programs to improve awareness and outcomes in women with heart disease. Met with leaders from ACC, SCAI-WIN, and ACOG to discuss ways in which members of the cardiology and OGYN specialties could work together to improve screening and detection of heart disease in women.

Presentation Title Date 10Company Confidential LTXXXXXXX ©2009 Abbott Laboratories Expected Outcomes Each site’s multi-disciplinary team will develop an algorithm to identify risk factors and establish a pathway for patients with risk factors to be referred to appropriate specialist(s) for further evaluation. Each site will utilize a minimum number of educational “opportunities” (dinner program, lunch and learn, grand rounds, etc) to improve the awareness, screening, diagnosis, and treatment of women with or at risk for heart disease. Sites will be expected to gather metrics of number of patients screened/identified/referred/interventions over a pre-specified period. (3-6 months??) Sites will be expected to participate in minimum of 2 webcasts/conference calls – 1 to roll out program and 1 to share best practices, discuss challenges/successes. SCAI-WIN leadership will take results to NHLBI or NIH to lobby for funding for a national education program